EP3551168A4 - Immunomodulatory compounds - Google Patents

Immunomodulatory compounds Download PDF

Info

Publication number
EP3551168A4
EP3551168A4 EP17877975.7A EP17877975A EP3551168A4 EP 3551168 A4 EP3551168 A4 EP 3551168A4 EP 17877975 A EP17877975 A EP 17877975A EP 3551168 A4 EP3551168 A4 EP 3551168A4
Authority
EP
European Patent Office
Prior art keywords
immunomodulatory compounds
immunomodulatory
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17877975.7A
Other languages
German (de)
French (fr)
Other versions
EP3551168A1 (en
Inventor
Susan Gilmour
Otto Phanstiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Central Florida Research Foundation Inc UCFRF
Lankenau Institute for Medical Research
Original Assignee
University of Central Florida Research Foundation Inc UCFRF
Lankenau Institute for Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Central Florida Research Foundation Inc UCFRF, Lankenau Institute for Medical Research filed Critical University of Central Florida Research Foundation Inc UCFRF
Publication of EP3551168A1 publication Critical patent/EP3551168A1/en
Publication of EP3551168A4 publication Critical patent/EP3551168A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/38—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
EP17877975.7A 2016-12-08 2017-12-08 Immunomodulatory compounds Withdrawn EP3551168A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662431663P 2016-12-08 2016-12-08
PCT/US2017/065305 WO2018107027A1 (en) 2016-12-08 2017-12-08 Immunomodulatory compounds

Publications (2)

Publication Number Publication Date
EP3551168A1 EP3551168A1 (en) 2019-10-16
EP3551168A4 true EP3551168A4 (en) 2020-07-15

Family

ID=62492364

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17877975.7A Withdrawn EP3551168A4 (en) 2016-12-08 2017-12-08 Immunomodulatory compounds

Country Status (8)

Country Link
US (1) US20190365673A1 (en)
EP (1) EP3551168A4 (en)
JP (1) JP2020500939A (en)
KR (1) KR20190093621A (en)
CN (1) CN110267649A (en)
AU (1) AU2017374043A1 (en)
CA (1) CA3046706A1 (en)
WO (1) WO2018107027A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11752113B2 (en) * 2020-09-09 2023-09-12 University Of Central Florida Research Foundation, Inc. Polyamine transport inhibitors as antivirals

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006279943B2 (en) * 2005-08-10 2012-02-16 The Johns Hopkins University Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
US9285320B2 (en) * 2008-05-01 2016-03-15 University Of Central Florida Research Foundation, Inc. Fluorescent cytotoxic compounds specific for the cellular polyamine transport system
WO2010148390A2 (en) * 2009-06-19 2010-12-23 University Of Central Florida Research Foundation, Inc. Polyamine transport inhibitors as novel therapeutics
US20110256161A1 (en) * 2010-04-19 2011-10-20 Aminex Therapeutics Inc. Methods for enhancing immune response
EP2830603B1 (en) * 2012-03-28 2018-09-26 University of Central Florida Research Foundation, Inc. Polyamine transport selective therapeutic agents with enhanced stability
PT2912193T (en) * 2012-10-29 2018-11-29 Arizona Board Of Regents On Behalf Of Univ Of Arizona Predictive markers for polyamine inhibitor cancer therapies

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AARON MUTH ET AL: "Polyamine Transport Inhibitors: Design, Synthesis, and Combination Therapies with Difluoromethylornithine", JOURNAL OF MEDICINAL CHEMISTRY, vol. 57, no. 2, 9 January 2014 (2014-01-09), US, pages 348 - 363, XP055536352, ISSN: 0022-2623, DOI: 10.1021/jm401174a *
CHELSEA MASSARO ET AL: "Investigation of Polyamine Metabolism and Homeostasis in Pancreatic Cancers", MEDICAL SCIENCES, vol. 5, no. 32, 7 December 2017 (2017-12-07), pages 1 - 14, XP055698087, DOI: 10.3390/medsci5040032 *
ERIC T. ALEXANDER ET AL: "A novel polyamine blockade therapy activates an anti-tumor immune response", ONCOTARGET, vol. 8, no. 48, 13 October 2017 (2017-10-13), United States, pages 84140 - 84152, XP055698084, ISSN: 1949-2553, DOI: 10.18632/oncotarget.20493 *
See also references of WO2018107027A1 *

Also Published As

Publication number Publication date
EP3551168A1 (en) 2019-10-16
JP2020500939A (en) 2020-01-16
CN110267649A (en) 2019-09-20
AU2017374043A1 (en) 2019-07-11
CA3046706A1 (en) 2018-06-14
US20190365673A1 (en) 2019-12-05
WO2018107027A1 (en) 2018-06-14
KR20190093621A (en) 2019-08-09

Similar Documents

Publication Publication Date Title
EP3474845A4 (en) Immunomodulator compounds
EP3564232A4 (en) Bmp-signal-inhibiting compound
EP3094351A4 (en) Immunomodulatory agents
EP3533799A4 (en) Compound
EP3464336A4 (en) Compounds
EP3402829A4 (en) Silicone-compatible compounds
EP3546496A4 (en) Compound
EP3524656A4 (en) Novel hydrogelator
EP3421542A4 (en) Compound
EP3551168A4 (en) Immunomodulatory compounds
EP3550018A4 (en) NOVEL ENDO-ß-N-ACETYLGLUCOSAMINIDASE
AU2016903778A0 (en) Compounds
AU2016904865A0 (en) Incentibuy
AU2016904616A0 (en) Bankgate
AU2016904425A0 (en) Neuro-Stimulant
AU2016903908A0 (en) fRecharge
AU2016903845A0 (en) RollAlong
AU2016903844A0 (en) Seedwalker
AU2016903803A0 (en) Putt-N-Pal
AU2016903627A0 (en) ShishiaPlus
AU2016903439A0 (en) Thermobrush
AU2016902907A0 (en) Improved Camber-Inducer
AU2016903334A0 (en) FittConnect
AU2016903303A0 (en) Gyrostabilisers
AU2016903360A0 (en) Eza-foot

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190704

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200615

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/127 20060101AFI20200608BHEP

Ipc: C07C 235/10 20060101ALI20200608BHEP

Ipc: C07C 233/38 20060101ALI20200608BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210113